GSA Capital Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-43,274
Closed -$1.57M 2084
2025
Q1
$1.57M Buy
+43,274
New +$1.57M 0.14% 146
2024
Q4
Sell
-11,508
Closed -$639K 1956
2024
Q3
$639K Sell
11,508
-4,067
-26% -$226K 0.05% 755
2024
Q2
$640K Buy
15,575
+5,026
+48% +$207K 0.04% 804
2024
Q1
$493K Buy
+10,549
New +$493K 0.04% 892
2023
Q2
Sell
-27,326
Closed -$1.1M 1870
2023
Q1
$1.1M Buy
+27,326
New +$1.1M 0.11% 268
2022
Q4
Sell
-10,560
Closed -$437K 1812
2022
Q3
$437K Buy
+10,560
New +$437K 0.06% 676
2022
Q2
Sell
-17,345
Closed -$1.26M 1730
2022
Q1
$1.26M Sell
17,345
-3,605
-17% -$262K 0.17% 110
2021
Q4
$1.76M Buy
+20,950
New +$1.76M 0.22% 40
2021
Q1
Sell
-3,084
Closed -$427K 1415
2020
Q4
$427K Buy
+3,084
New +$427K 0.07% 521
2020
Q1
Sell
-10,129
Closed -$433K 1465
2019
Q4
$433K Buy
10,129
+2,170
+27% +$92.8K 0.05% 762
2019
Q3
$340K Buy
+7,959
New +$340K 0.05% 802
2019
Q2
Sell
-2,900
Closed -$201K 1681
2019
Q1
$201K Buy
+2,900
New +$201K 0.02% 1237
2018
Q3
Sell
-10,582
Closed -$813K 1844
2018
Q2
$813K Sell
10,582
-7,018
-40% -$539K 0.04% 878
2018
Q1
$897K Buy
+17,600
New +$897K 0.05% 734
2016
Q1
Sell
-11,188
Closed -$1.26M 1877
2015
Q4
$1.26M Buy
11,188
+1,218
+12% +$137K 0.06% 533
2015
Q3
$960K Buy
9,970
+1,170
+13% +$113K 0.05% 669
2015
Q2
$901K Buy
8,800
+3,700
+73% +$379K 0.03% 985
2015
Q1
$317K Sell
5,100
-5,648
-53% -$351K 0.01% 1683
2014
Q4
$472K Buy
+10,748
New +$472K 0.03% 963